Treatment by Slow-released salbuterol for patients with asthma
10.3321/j.issn:1000-5404.2001.02.013
- VernacularTitle:国产缓释沙丁胺醇治疗支气管哮喘的随机对照试验
- Author:
Chang-Zheng WANG
1
;
Shun-Chao WANG
;
Jian-Chun WANG
;
Ze-Yun ZHOU
;
Gui-Sheng QIAN
Author Information
1. 第三军医大学附属新桥医院
- From:Journal of Third Military Medical University
2001;23(2):157-159
- CountryChina
- Language:Chinese
-
Abstract:
Objective In a RCT study, the safety and efficacy of sabot (a slow-release salbuteral) and volmax (controlled-release salbuterol) were compared in bronchial asthma. Methods 40 patients with moderate to severe asthma were randomly divided into two groups and treated by sabot or volmax for 2 weeks. The FEV1%, peak expiratory flow (PEF), symptom score and use of rescue ventolin were measured to evaluate the effect of treatment. Results After treatment FEV1%, PEF and symptom score improved and the need for inhaling short-acting beta 2-agonis in both groups reduced significantly. There was no difference of these improvement between two groups. Conclusion The safety and efficacy of sabot for treatment of asthma was similar to volmax.
